Moran Kevin Patrick

CIK 00018065961 companyWASHINGTON, DC

SEC Profile

Transactions

Companies

Filings

CIK

0001806596

Recent Transactions

31 trades

Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2026-03-02$8.27/sh−42,442→ 411,380 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2026-02-18+125,000→ 453,822 total
Tax Payment
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2025-03-01$4.76/sh−26,941→ 328,822 total
Purchase
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2025-02-21$4.39/sh+2,000→ 355,763 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2025-02-18+125,000→ 353,763 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2024-07-29$5.92/sh−2,251→ 228,763 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2024-03-05$4.20/sh−8,902→ 231,014 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2024-03-04$4.48/sh−5,798→ 239,916 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2024-02-16+125,000→ 245,714 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2023-07-28$6.30/sh−412→ 122,514 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2023-07-28$6.30/sh−1,800→ 120,714 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2023-06-15$6.29/sh−16,000→ 122,926 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2023-03-03$6.28/sh−5,968→ 138,926 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2023-03-02$6.26/sh−7,966→ 144,894 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2023-02-16+32,700→ 152,860 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Stock Option (Right to Buy)
2023-02-16+77,500→ 77,500 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2022-12-06$10.61/sh−4,792→ 120,160 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Stock Option (Right to Buy)
2022-12-06−7,500→ 0 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2022-12-06$3.12/sh+7,500→ 124,952 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2022-07-28$10.97/sh−2,239→ 117,452 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2022-03-02$11.28/sh−8,832→ 119,691 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2022-03-01$11.19/sh−3,473→ 128,523 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Stock Option (Right to Buy)
2022-02-28+77,500→ 77,500 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2022-02-28+32,700→ 131,996 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-07-28$19.24/sh−2,130→ 99,296 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-03-02$18.23/sh−6,044→ 101,426 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-03-01$18.57/sh−3,327→ 107,470 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2021-02-24+77,500→ 77,500 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-02-24+32,700→ 110,797 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Stock Option (Right to Buy)
2020-07-27+90,000→ 90,000 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2020-07-27+17,344→ 78,097 total

Companies

Vanda Pharmaceuticals Inc.
SVP, CFO & Treasurer
$VNDA

Recent Filings

Address

2200 PENNSYLVANIA AVENUE NW SUITE 300E

WASHINGTON, DC, 20037

View on SEC.gov